Page last updated: 2024-10-20

pyridoxine and Peripheral Arterial Disease

pyridoxine has been researched along with Peripheral Arterial Disease in 1 studies

4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).

Peripheral Arterial Disease: Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BRANZI, G1
ANNINO, G1

Other Studies

1 other study available for pyridoxine and Peripheral Arterial Disease

ArticleYear
[Therapy of peripheral arteriopathies with a compound with a base of inositol hexanicotinate].
    La Riforma medica, 1963, Jan-19, Volume: 77

    Topics: Inositol; Niacin; Nicotinic Acids; Peripheral Arterial Disease; Peripheral Vascular Diseases; Pyrido

1963